These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9726350)

  • 1. Off label use of antimicrobial agents in infants, children and adolescents: a time for action.
    Abramson JS; Holland ME
    Pediatr Infect Dis J; 1998 Aug; 17(8):739-44. PubMed ID: 9726350
    [No Abstract]   [Full Text] [Related]  

  • 2. Is pediatric labeling really necessary?
    Christensen ML; Helms RA; Chesney RW
    Pediatrics; 1999 Sep; 104(3 Pt 2):593-7. PubMed ID: 10469796
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of US Food and Drug Administration-Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail Setting.
    Xu J; Gill R; Cruz M; Staffa J; Lurie P
    JAMA Pediatr; 2016 Nov; 170(11):1103-1104. PubMed ID: 27612007
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic orphans.
    Shirkey H
    Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on the therapeutic orphan.
    Wilson JT
    Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
    [No Abstract]   [Full Text] [Related]  

  • 6. Off-label uses of drugs in children.
    Blumer JL
    Pediatrics; 1999 Sep; 104(3 Pt 2):598-602. PubMed ID: 10469797
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems of drug testing in children in the United States.
    Yaffe SJ
    Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
    [No Abstract]   [Full Text] [Related]  

  • 8. The antibiotic pipeline in pediatrics.
    McCracken GH
    Adv Exp Med Biol; 2009; 634():147-51. PubMed ID: 19280856
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA set to expand pediatric information in drug product labeling.
    Am J Health Syst Pharm; 1995 Feb; 52(4):358. PubMed ID: 7757855
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. After Amarin v FDA: What Will the Future Hold for Off-label Promotion Regulation?
    Mackey TK; Liang BA
    Mayo Clin Proc; 2016 Jun; 91(6):701-6. PubMed ID: 27084416
    [No Abstract]   [Full Text] [Related]  

  • 12. Plans to restrict 'extra-label' use of cephalosporins in the USA.
    Vet Rec; 2012 Feb; 170(6):142. PubMed ID: 22331777
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating the off-label use of medications in children.
    Eiland LS; Knight P
    Am J Health Syst Pharm; 2006 Jun; 63(11):1062-5. PubMed ID: 16709893
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Lopinavir/ritonavir label updated.
    AIDS Alert; 2008 Aug; 23(8):92. PubMed ID: 18727173
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceuticals for infants and children.
    Silver J
    AIDS Patient Care STDS; 1997 Jun; 11(3):191-2. PubMed ID: 11361793
    [No Abstract]   [Full Text] [Related]  

  • 17. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 18. The march toward rational therapeutics in children.
    Gorman RL
    Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children, drugs, and the Food and Drug Administration: studies of pediatric drugs are beginning to catch up.
    Ward RM
    Pediatr Ann; 2001 Apr; 30(4):189-94. PubMed ID: 11303433
    [No Abstract]   [Full Text] [Related]  

  • 20. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.